Thursday, June 23, 2016

BRIEF-Teva settles patent litigation with AstraZeneca

* Teva settles patent litigation with AstraZeneca allowing

Teva to commercialize its generic version of Byetta (Exenatide

injection) in the United States

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)